An investigation for investors in Amarin Corporation plc (NASDAQ: AMRN) shares over potential securities laws violations by Amarin Corporation plc was announced.
San Diego, CA -- (SBWIRE) -- 12/06/2018 -- Amarin Corporation is under investigation over potential securities laws violations by Amarin Corporation plc and certain of its directors and officers in connection with certain financial statements.
Investors who purchased shares of Amarin Corporation plc (NASDAQ: AMRN) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) concerning whether a series of statements by Amarin Corporation plc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Ireland based Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. On November 12, 2018, an article was published, entitled "Amarin's REDUCE-IT Trial: Something Fishy?" The article addressed Amarin's "recent revelations of positive topline results" from its REDUCE-IT trial for Vascepa, its sole product. Specifically, the article raised the possibility that "the placebo group received an active agent that in effect was an anti-statin", and that the REDUCE-IT trial results may have consequently exaggerated the efficacy of Vascepa.
Shares of Amarin Corporation plc (NASDAQ: AMRN) declined to as low as $13.56 per share on November 14, 2018.
Those who purchased shares of Amarin Corporation plc (NASDAQ: AMRN) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels